Utilizing an MHC-mismatched murine transplantation model, Dutt and colleagues demonstrated that genetic deletion of α4β7 integrin alone was insufficient to protect mice from lethal GVHD; but rather the deletion of both α4β7 and CD62L together were required to protect mice from GVHD (83). The gene discussed is SELL; the disease is graft versus host disease.